Travaux scientifiques

Dr. Öğr. Üyesi Cengiz Akosman

22 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15020642 PMID 41598581 Texte intégral en libre accèsSource : ORCID

  2. Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients

    Scientific reports, 2026

    DOI 10.1038/s41598-026-50526-x PMID 42103792 Texte intégral en libre accèsSource : Europe PMC

  3. The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

    Discover oncology, 2026

    DOI 10.1007/s12672-026-04705-x PMID 41721952 Texte intégral en libre accèsSource : Europe PMC

  4. Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab

    Scientific reports, 2026

    DOI 10.1038/s41598-026-48955-9 PMID 41981174 Texte intégral en libre accèsSource : Europe PMC

  5. Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis

    The oncologist, 2026

    DOI 10.1093/oncolo/oyag092 PMID 41838398 Texte intégral en libre accèsSource : ORCID

  6. Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancer

    Expert review of anticancer therapy, 2026

    DOI 10.1080/14737140.2026.2615853 PMID 41511755 2 citations (Europe PMC) Source : ORCID

  7. Somatic mutation profiling by NGS-based liquid biopsy in advanced non-small cell lung cancer: frequency, clinical correlates, and prognostic significance

    Molecular biology reports, 2026

    DOI 10.1007/s11033-026-11971-z PMID 42176127 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  8. Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16667-y PMID 42693417 Texte intégral en libre accèsSource : OpenAlex

  9. Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1756315 PMID 42482752 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  10. Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04859-8 PMID 42014558 Texte intégral en libre accèsSource : OpenAlex

  11. Analysis of the results of the BRCA1 and BRCA2 genes in early-onset breast cancer patients from the Ordu province

    The Atlantic Journal of Medical Science and Research, 2026

    DOI 10.5455/atjmed.2025.11.036 Texte intégral en libre accèsSource : OpenAlex

  12. İç Hastalıklar Semiyoloji ve Ötesi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1957 Source : OpenAlex

  13. Evaluation of videodermoscopic features of chemotherapy induced alopecias,Kemoterapi ile İndüklenen Alopesilerde Videodermoskopik Bulguların Değerlendirilmesi

    Turkiye Klinikleri Dermatoloji, 2020

    DOI 10.5336/dermato.2019-73099 Texte intégral en libre accèsSource : ORCID

  14. Bilateral synchronous adrenal metastasis of invasive ductal carcinoma treated with multimodality therapy including adrenalectomy and oophorectomy

    Journal of Oncology Pharmacy Practice, 2016

    DOI 10.1177/1078155214551314 PMID 25227232 3 citations (Europe PMC) Source : ORCID

  15. Comparison of Metabolic and Anatomic Response to Chemotherapy Based on PERCIST and RECIST in Patients with Advanced Stage Non-small Cell Lung Cancer

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.1.321 PMID 25640373 12 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  16. Development of Acute Pulmonary Hypertension After Bortezomib Treatment in a Patient With Multiple Myeloma

    American Journal of Therapeutics, 2015

    DOI 10.1097/01.mjt.0000433941.91996.5f PMID 24100255 11 citations (Europe PMC) Source : ORCID

  17. Development of Acute Pulmonary Hypertension After Bortezomib Treatment in a Patient With Multiple Myeloma: A Case Report and the Review of the Literature

    AMERICAN JOURNAL OF THERAPEUTICS, 2015

    Source : ORCID

  18. Large Cell Neuroendocrine Tumor of Gallbladder: A Case Report and Review of the Literature

    Turkiye Klinikleri Journal of Case Reports, 2013

    Source : OpenAlex

  19. The acute effects of palonosetron on ECG parameters in patients with cancer

    JOURNAL OF CLINICAL ONCOLOGY, 2011

    DOI 10.1200/jco.2011.29.15_suppl.e19693 2 citations (OpenAlex) Source : ORCID

  20. The early metabolic effect of zolendronic acid on FDG-PET scans in patients with bone metastasis

    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011

    DOI 10.1200/jco.2011.29.15_suppl.e21168 Source : ORCID

  21. The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small cell lung cancer

    JOURNAL OF CLINICAL ONCOLOGY, 2011

    DOI 10.1200/jco.2011.29.15_suppl.e18055 1 citation (OpenAlex) Source : ORCID

  22. Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment

    Cancer Imaging, 2011

    DOI 10.1102/1470-7330.2011.0011 PMID 21684830 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID